Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers have?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has 577 citations in the OpenAlex counts ScholarIQ stores.
When was Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers published?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has 2017 year in the ScholarIQ index.
What is the open-access status of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has bronze oa status in the ScholarIQ index.
What is the DOI of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The DOI for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.
What is the PMID of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The PMID for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.
What is the OpenAlex record for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The OpenAlex for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.